Meet a Killer

. Sunday, August 24

While waiting for pharmaceutical companies to embrace and run with nanotechnology that will do the trick, scientists have been refining antibody engineering.  These antibody cells recognize and attack cancer cells in the body by delivering a payload of powerful poison. The scientists first loaded the antibody cells with poison, and that caused problems with the liver and kidneys.  They found that, by limiting the amount of poison per antibody cell, the side effects were minimal, yet the cancers were demolished.  Now that is good news.